Yatian Liu
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
ASO Visual Abstract: Safety and Survival Outcomes of Neoadjuvant Chemoradiotherapy Combined with Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Analysis (NEO-EC-01).
Journal: Annals of surgical oncology
Published: February 27, 2026
Interaction between human oxoguanine glycosylase 1 gene polymorphisms and smoking status on nasopharyngeal carcinoma risk.
Journal: Journal of human genetics
Published: December 09, 2025
Exploratory analysis of prognostic factors and hematologic dynamics in unresectable ESCC treated with concurrent versus interval immune checkpoint inhibitors combined with (chemo)radiotherapy: a multicenter real-world study.
Journal: Frontiers in immunology
Published: October 20, 2025
Safety and Survival Outcomes of Neoadjuvant Chemoradiotherapy Combined with Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Real-World Analysis (NEO-EC-01).
Journal: Annals of surgical oncology
Published: September 12, 2025
Analysis of lymph node recurrence patterns and risk factors in locally advanced esophageal carcinoma following neoadjuvant therapy.
Journal: Frontiers in oncology
Published: July 18, 2025
Impact of first-line chemoimmunotherapy with or without radiotherapy on the prognosis of patients with locally advanced or metastatic esophageal squamous cell carcinoma: a multicenter, real-world, retrospective cohort study from China (NCT06478355).
Journal: Frontiers in immunology
Published: May 23, 2025
Dosimetric effects of the leaf positioning error of the halcyon(2.0) dual-layer multileaf collimator (MLC) on the rectal cancer radiotherapy.
Journal: Medical dosimetry : official journal of the American Association of Medical Dosimetrists
Published: June 16, 2024
Comparison of immunochemotherapy followed by surgery or chemoradiotherapy in locally advanced esophageal squamous cell cancer.
Journal: International immunopharmacology
Published: December 25, 2023
Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial.
Journal: EClinicalMedicine
Published: September 26, 2023
LINC00261 Suppresses Cisplatin Resistance of Esophageal Squamous Cell Carcinoma Through miR-545-3p/MT1M Axis.
Journal: Frontiers in cell and developmental biology
Published: March 30, 2021
miR-17-5p and miR-4443 Promote Esophageal Squamous Cell Carcinoma Development by Targeting TIMP2.
Journal: Frontiers in oncology
Published: September 13, 2020
Last Updated: 09/26/2026